Petros Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Petros Pharmaceuticals, Inc. (PTPI) had Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized of 40.11 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized · last filed 2026-08-13
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 40.11M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 40.11M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 40.11M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 2.76M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized |
|---|---|
| 2026-06-30 | 40.11M shares 10-Q · filed 2026-08-13 |
| 2026-03-31 | 40.11M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 40.11M shares 10-K · filed 2026-04-15 |
| 2024-12-31 | 2.76M shares 10-K · filed 2025-03-31 |
| 2023-12-31 | 2.76M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 2.76M shares 10-Q · filed 2023-11-15 |
| 2023-06-30 | 260.00K shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 260.00K shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 260.00K shares 10-K · filed 2023-03-31 |
| 2022-09-30 | 2.60M shares 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | 2.60M shares 10-Q · filed 2022-08-12 |
| 2022-01-31 | 2.60M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 2.60M shares 10-K · filed 2022-03-31 |
| 2021-09-30 | 1.21M shares 10-Q · filed 2021-11-15 |
| 2021-06-30 | 1.21M shares 10-Q · filed 2021-08-16 |
| 2021-03-31 | 1.08M shares 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |